Health Care & Life Sciences » Pharmaceuticals | Pyridam Farma

Pyridam Farma | Income Statement

Fiscal year is January-December. All values IDR Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
192,556
222,302
217,844
216,952
223,002
250,446
Cost of Goods Sold (COGS) incl. D&A
65,353
83,367
79,589
83,298
88,575
100,257
Gross Income
127,202
138,935
138,255
133,653
134,427
150,189
SG&A Expense
117,476
131,556
128,907
123,431
122,612
134,982
EBIT
9,105
-
9,348
10,222
11,815
15,206
Non Operating Income/Expense
2,599
2,814
788
297
247
698
Interest Expense
3,215
5,990
5,586
3,470
2,469
3,206
Pretax Income
8,500
4,211
4,555
7,053
9,599
11,317
Income Tax
2,304
1,550
1,468
1,907
2,472
2,870
Consolidated Net Income
6,196
2,661
3,087
5,146
7,127
8,447
Net Income
6,196
2,661
3,087
5,146
7,127
8,447
Net Income After Extraordinaries
6,196
2,661
3,087
5,146
7,127
8,447
Net Income Available to Common
6,196
2,661
3,087
5,146
7,127
8,447
EPS (Basic)
11.58
4.97
5.77
9.62
13.32
15.79
Basic Shares Outstanding
535
535
535
535
535
535
EPS (Diluted)
11.58
4.97
5.77
9.62
13.32
15.79
Diluted Shares Outstanding
535
535
535
535
535
535
EBITDA
17,104
18,229
19,363
19,403
20,432
22,503
Other Operating Expense
621
-
-
-
-
-
Non-Operating Interest Income
10
7
6
5
6
14

About Pyridam Farma

View Profile
Address
Ruko Villa Kebon Jeruk
Jakarta JK 11530
Indonesia
Employees -
Website http://www.pyridam.com
Updated 07/08/2019
PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines and trading of medical equipment. The firm operates through the following segments: Pharmaceutical Products and Toll Manufacturing Services; and Medical Equipment Products. It manufactures and distributes medicine types such as analgesics, anti-anemic, anti-hypertension, antibiotics, anti-rheumatics, antacids, anti-diabetics, multivitamins, anti-inflammatory, and disinfectants.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.